Exact Sciences earnings were -$214.0M for the trailing 12 months ending Sep 30, 2024, with N/A growth year over year. The latest EXAS earnings report on Sep 30, 2024 announced Q3 2024 earnings of -$38.2M, up 141.9% from last quarter. For the last reported fiscal year 2023 ending Dec 31, 2023, EXAS reported annual earnings of -$204.1M, with -67.3% growth. The next EXAS earnings date is Feb 19, 2025.
On EXAS's earnings call on Invalid Date, Exact Sciences (NASDAQ: EXAS) reported Q3 2024 earnings per share (EPS) of -$0.21, up Infinity% year over year. Total EXAS earnings for the quarter were -$38.24 million. In the same quarter last year, Exact Sciences's earnings per share (EPS) was $0.00.
The next EXAS earnings call is Invalid Date. Add EXAS to your watchlist to be reminded of Exact Sciences's next earnings date.
Is Exact Sciences profitable or losing money?
As of the last Exact Sciences earnings report, Exact Sciences is currently losing money. Exact Sciences's net profit (also called net income) for the twelve months ending Sep 30, 2024 was -$214.04 million, a 24.13% decrease year over year.
What was EXAS's earnings growth in the past year?
As of Exact Sciences's earnings date in Invalid Date, Exact Sciences's earnings has grown year over year. EXAS earnings in the past year totalled -$214.04 million.
What are Exact Sciences's earnings expectations?
The current EPS estimate for Exact Sciences's earnings report in Invalid Date is -$0.33.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.